Intuitive Surgical (ISRG) Stock Forecast & Price Target

$482.84 -9.00 (-1.83%)

As of 10:22 AM Eastern

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 21 Analyst Ratings

Sell
1

Hold
5

Buy
15

Based on 21 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 1 has given a sell rating, 5 have given a hold rating, and 15 have given a buy rating for ISRG.

Consensus Price Target

$611.86
26.72% Upside

According to the 21 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $611.86. The highest price target for ISRG is $711.00, while the lowest price target for ISRG is $500.00. The average price target represents a forecasted upside of 26.72% from the current price of $482.84.

Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

ISRG Analyst Ratings Over Time

Type	Current Forecast 3/31/24 to 3/31/25	1 Month Ago 3/1/24 to 3/1/25	3 Months Ago 1/1/24 to 12/31/24	1 Year Ago 4/1/23 to 3/31/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	16 Buy rating(s)	15 Buy rating(s)	15 Buy rating(s)
Hold	5 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$611.86	$613.10	$554.17	$371.60
Forecasted Upside	26.72% Upside	6.97% Upside	6.17% Upside	-6.89% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Remove Ads

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intuitive Surgical Stock vs. The Competition

Type	Intuitive Surgical	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.82	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	24.40% Upside	18,545.92% Upside	19.88% Upside
News Sentiment Rating	Positive News See Recent ISRG News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/18/2025	Robert W. Baird 2 of 5 stars	David Rescott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$707.00 ➝ $600.00	+22.75%
3/17/2025	Erste Group Bank 3 of 5 stars	H. Engel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/17/2025	Truist Financial 2 of 5 stars	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$666.00 ➝ $605.00	+24.89%
1/27/2025	CICC Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$550.00	-4.17%
1/27/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$490.00 ➝ $530.00	-7.65%
1/27/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$500.00 ➝ $560.00	-2.35%
1/27/2025	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$490.00 ➝ $548.00	-4.43%
1/27/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$611.00 ➝ $641.00	+11.81%
1/27/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$475.00 ➝ $575.00	+0.30%
1/27/2025	Bernstein Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$655.00 ➝ $700.00	+22.16%
Get the Latest News and Ratings for ISRG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors with MarketBeat's FREE daily newsletter.
1/27/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$610.00 ➝ $674.00	+17.62%
1/24/2025	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jayson Bedford Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$560.00 ➝ $688.00	+17.20%
1/24/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adam Maeder Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$538.00 ➝ $670.00	+14.12%
1/24/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$630.00 ➝ $687.00	+18.38%
1/24/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$640.00 ➝ $711.00	+16.81%
1/24/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robbie Marcus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$575.00 ➝ $675.00	+10.90%
12/5/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$525.00 ➝ $610.00	+11.22%
12/2/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$522.00 ➝ $650.00	+19.93%
11/26/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$535.00 ➝ $561.00	+3.85%
10/18/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$604.00	+15.73%
10/18/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Perform ➝ Market Perform
10/17/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$440.00 ➝ $500.00	+5.30%
8/2/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Ridley-Day Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$380.00 ➝ $510.00	+13.10%
11/17/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$318.00	+4.62%
5/31/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$350.00 ➝ $365.00	+18.87%
4/19/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold	$245.00 ➝ $290.00	-4.27%
4/19/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$300.00 ➝ $315.00	+16.98%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:32 AM ET.

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, March 27, 2025. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

Intuitive Surgical, Inc. has received multiple upgrades from analysts, with Piper Sandler raising its target price to $670.00 and Raymond James to $688.00, indicating strong market confidence in the company's growth potential.
The stock currently trades at approximately $508.46, which is significantly above its 12-month low of $364.17, suggesting a recovery and potential for further appreciation.
With a consensus rating of "Moderate Buy" and an average price target of $611.86, there is a positive outlook among analysts, which could attract more investors.
Intuitive Surgical, Inc. is a leader in robotic surgery innovation, which positions it well in a growing market focused on minimally invasive procedures, enhancing its long-term growth prospects.
Insider activity shows confidence, with executives holding shares despite recent sales, indicating they believe in the company's future performance.

Intuitive Surgical
Bear Case

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

The stock has a high P/E ratio of 79.32, which may indicate that it is overvalued compared to its earnings, potentially leading to a price correction.
Recent insider sales, including significant transactions by executives, could signal a lack of confidence in the stock's short-term performance, raising concerns for potential investors.
Despite the positive outlook, the company has faced a downgrade from Erste Group Bank, which may reflect underlying concerns about its market position or financial health.
The stock's beta of 1.43 suggests higher volatility compared to the market, which could lead to greater risk for investors during market fluctuations.
With only 0.90% of shares owned by insiders, there may be less alignment between management and shareholder interests, which can be a red flag for potential investors.

ISRG Forecast - Frequently Asked Questions

: According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $611.86, with a high forecast of $711.00 and a low forecast of $500.00.
: 21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last year. There is currently 1 sell rating, 5 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ISRG shares.
: According to analysts, Intuitive Surgical's stock has a predicted upside of 26.72% based on their 12-month stock forecasts.
: Over the previous 90 days, Intuitive Surgical's stock had 1 downgrade by analysts.
: Intuitive Surgical has been rated by research analysts at Barclays, Bernstein Bank, CICC Research, Citigroup, Erste Group Bank, Evercore ISI, Jefferies Financial Group, JPMorgan Chase & Co., Leerink Partners, Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Intuitive Surgical less than other "medical" companies. The consensus rating score for Intuitive Surgical is 2.67 while the average consensus rating score for "medical" companies is 2.82. Learn more on how ISRG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:ISRG) was last updated on 3/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intuitive Surgical (ISRG) Stock Forecast & Price Target